{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:03:06Z","timestamp":1791295386716,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:00:00Z","timestamp":1317168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Drug susceptibility testing (DST) remains an important concern for implementing treatment of MDR tuberculosis patients. Implementation of molecular tests for drug resistance identification would facilitate DST particularly in developing countries where culturing is difficult to perform. We have characterized multidrug resistant strains in Cambodia using MDTDR<jats:italic>sl<\/jats:italic> tests, drug target sequencing and phenotypic tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 65 non-MDR and 101 MDR TB isolates collected between May 2007 and June 2009 were tested for resistance to fluoroquinolones and aminoglycosides\/cyclic peptides using the GenoType<jats:sup>\u00ae<\/jats:sup> MTBDR<jats:italic>sl<\/jats:italic> assay and gene sequencing. Rifampicin resistance (RMP-R) was tested using gene sequencing and genotyping was assessed by spoligotyping.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 95 of the 101 MDR strains were confirmed to be RMP-R by <jats:italic>rpoB<\/jats:italic> gene sequencing. Fourteen of the 101 MDR isolates (14%) carried a <jats:italic>gyrA<\/jats:italic> mutation associated with fluoroquinolone-resistance (FQ-R) (detected by the MTBDR<jats:italic>sl<\/jats:italic> assay and sequencing) compared with only 1 (1.5%) of the 65 non-MDR strains. Only 1 (1%) of the MDR isolates was found to be XDR TB. The MDR group contained a higher proportion of Beijing or Beijing like strains (58%) than the non MDR group (28%). This percentage is higher in MDR FQ-R strains (71%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The new GenoType<jats:sup>\u00ae<\/jats:sup> MTBDR<jats:italic>sl<\/jats:italic> assay combined with molecular tests to detect RMP-R and isoniazid resistance (INH-R) represents a valuable tool for the detection of XDR TB. In Cambodia there is a low rate of XDR amongst MDR TB including MDR FQ-R TB. This suggests a low association between FQ-R and XDR TB. Strain spoligotyping confirms Beijing strains to be more prone to accumulate antibiotic resistance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-11-255","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T18:20:40Z","timestamp":1317234040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes"],"prefix":"10.1186","volume":"11","author":[{"given":"Corinne","family":"Surcouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiha","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pierre-Audigier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Cadet-Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Namouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gicquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"1599_CR1","volume-title":"Global tuberculosis control","author":"2010 Wr","year":"2010","unstructured":"2010 Wr: Global tuberculosis control. 2010"},{"key":"1599_CR2","volume-title":"WHO report","author":"Organization. WH","year":"2009","unstructured":"Organization. WH: GLobal tuberculosis control: epidemiology, strategy, financing. WHO\/HTM\/TB\/2009.411. Geneva, Switzerland: WHO, 2009. WHO report. 2009"},{"issue":"12","key":"1599_CR3","first-page":"1321","volume":"11","author":"N Yamada","year":"2007","unstructured":"Yamada N, Saorith K, Yamakami K, Onozaki I, Boran S, Fujiki A, Eang MT, Mori T: The national tuberculosis drug resistance survey in Cambodia, 2000-2001. Int J Tuberc Lung Dis. 2007, 11 (12): 1321-1327.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"1599_CR4","first-page":"104","volume":"40","author":"B Sar","year":"2009","unstructured":"Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, Monchy D, Sarthou JL: Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health. 2009, 40 (1): 104-107.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"1599_CR5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/jcm.35.4.907-914.1997","volume":"35","author":"J Kamerbeek","year":"1997","unstructured":"Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35 (4): 907-914.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1599_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1128\/JCM.00750-06","volume":"45","author":"J Sekiguchi","year":"2007","unstructured":"Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, et al: Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2007, 45 (1): 179-192. 10.1128\/JCM.00750-06.","journal-title":"J Clin Microbiol"},{"issue":"18","key":"1599_CR7","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1073\/pnas.94.18.9869","volume":"94","author":"S Sreevatsan","year":"1997","unstructured":"Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM: Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA. 1997, 94 (18): 9869-9874. 10.1073\/pnas.94.18.9869.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1599_CR8","unstructured":"Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kelembho E, Barilone N, Zandanga G, Rauzier J, Cadet-Daniel V, Le Faou A, Gicquel B: Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis. 14 (6): 782-785."},{"key":"1599_CR9","doi-asserted-by":"crossref","unstructured":"Ando H, Mitarai S, Kondo Y, Suetake T, Sekiguchi JI, Kato S, Mori T, Kirikae T: Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan. Clin Microbiol Infect. 16 (8): 1164-1168.","DOI":"10.1111\/j.1469-0691.2009.03078.x"},{"issue":"7","key":"1599_CR10","first-page":"802","volume":"10","author":"GE Louw","year":"2006","unstructured":"Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young DB, Victor TC: Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis. 2006, 10 (7): 802-807.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2 Suppl 1","key":"1599_CR11","first-page":"S4","volume":"4","author":"PF Riska","year":"2000","unstructured":"Riska PF, Jacobs WR, Alland D: Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis. 2000, 4 (2 Suppl 1): S4-10.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1599_CR12","unstructured":"2010, [http:\/\/www.moleculartb.org]"},{"issue":"5","key":"1599_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1177\/147323000903700517","volume":"37","author":"H Zhang","year":"2009","unstructured":"Zhang H, Bi LJ, Li CY, Sun ZG, Deng JY, Zhang XE: Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China. J Int Med Res. 2009, 37 (5): 1430-1435.","journal-title":"J Int Med Res"},{"issue":"4","key":"1599_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/505877","volume":"194","author":"M Zignol","year":"2006","unstructured":"Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C: Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006, 194 (4): 479-485. 10.1086\/505877.","journal-title":"J Infect Dis"},{"issue":"5","key":"1599_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/infdis\/174.5.1127","volume":"174","author":"C Xu","year":"1996","unstructured":"Xu C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K: Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis. 1996, 174 (5): 1127-1130. 10.1093\/infdis\/174.5.1127.","journal-title":"J Infect Dis"},{"issue":"8","key":"1599_CR16","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.40.8.1768","volume":"40","author":"T Kocagoz","year":"1996","unstructured":"Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF: Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1996, 40 (8): 1768-1774.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1599_CR17","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/jac\/dki353","volume":"56","author":"TS Huang","year":"2005","unstructured":"Huang TS, Kunin CM, Shin-Jung Lee S, Chen YS, Tu HZ, Liu YC: Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother. 2005, 56 (6): 1058-1062. 10.1093\/jac\/dki353.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1599_CR18","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/AAC.00177-09","volume":"53","author":"P Xu","year":"2009","unstructured":"Xu P, Li X, Zhao M, Gui X, DeRiemer K, Gagneux S, Mei J, Gao Q: Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob Agents Chemother. 2009, 53 (7): 3170-3172. 10.1128\/AAC.00177-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1599_CR19","first-page":"260","volume":"13","author":"F Brossier","year":"2009","unstructured":"Brossier F, Veziris N, Jarlier V, Sougakoff W: Performance of MTBDR plus for detecting high\/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis. 2009, 13 (2): 260-265.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"1599_CR20","first-page":"546","volume":"5","author":"ER Grimaldo","year":"2001","unstructured":"Grimaldo ER, Tupasi TE, Rivera AB, Quelapio MI, Cardano RC, Derilo JO, Belen VA: Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Int J Tuberc Lung Dis. 2001, 5 (6): 546-550.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"1599_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1086\/427292","volume":"40","author":"L Bozeman","year":"2005","unstructured":"Bozeman L, Burman W, Metchock B, Welch L, Weiner M: Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Clin Infect Dis. 2005, 40 (3): 386-391. 10.1086\/427292.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1599_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10096-004-1268-4","volume":"24","author":"Y Balabanova","year":"2005","unstructured":"Balabanova Y, Ruddy M, Hubb J, Yates M, Malomanova N, Fedorin I, Drobniewski F: Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis. 2005, 24 (2): 136-139. 10.1007\/s10096-004-1268-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"1599_CR23","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1128\/JCM.00081-09","volume":"47","author":"D Hillemann","year":"2009","unstructured":"Hillemann D, Rusch-Gerdes S, Richter E: Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol. 2009, 47 (6): 1767-1772. 10.1128\/JCM.00081-09.","journal-title":"J Clin Microbiol"},{"key":"1599_CR24","doi-asserted-by":"crossref","unstructured":"Kiet VS, Lan NT, An DD, Dung NH, Hoa DV, van Vinh Chau N, Chinh NT, Farrar J, Caws M: Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 48 (8): 2934-2939.","DOI":"10.1128\/JCM.00201-10"},{"issue":"8","key":"1599_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1056\/NEJM199302253280802","volume":"328","author":"M Goble","year":"1993","unstructured":"Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR: Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993, 328 (8): 527-532. 10.1056\/NEJM199302253280802.","journal-title":"N Engl J Med"},{"issue":"14","key":"1599_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM199510053331404","volume":"333","author":"EE Telzak","year":"1995","unstructured":"Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, el-Sadr W, Blum S, Gagliardi A, Salomon N, Turett G: Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med. 1995, 333 (14): 907-911. 10.1056\/NEJM199510053331404.","journal-title":"N Engl J Med"},{"issue":"9670","key":"1599_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(09)60333-0","volume":"373","author":"MB Conde","year":"2009","unstructured":"Conde MB, Efron A, Loredo C, De Souza GR, Graca NP, Cezar MC, Ram M, Chaudhary MA, Bishai WR, Kritski AL, et al: Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet. 2009, 373 (9670): 1183-1189. 10.1016\/S0140-6736(09)60333-0.","journal-title":"Lancet"},{"issue":"2","key":"1599_CR28","first-page":"128","volume":"12","author":"R Rustomjee","year":"2008","unstructured":"Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T, Reddy C, Sturm AW, Sirgel FA, Allen J, et al: A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (2): 128-138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"14","key":"1599_CR29","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2165\/00003495-200767140-00007","volume":"67","author":"S Moadebi","year":"2007","unstructured":"Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F: Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs. 2007, 67 (14): 2077-2099. 10.2165\/00003495-200767140-00007.","journal-title":"Drugs"},{"issue":"5","key":"1599_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/jac\/dkm061","volume":"59","author":"JY Wang","year":"2007","unstructured":"Wang JY, Lee LN, Lai HC, Wang SK, Jan IS, Yu CJ, Hsueh PR, Yang PC: Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. J Antimicrob Chemother. 2007, 59 (5): 860-865. 10.1093\/jac\/dkm061.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1599_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3201\/eid1405.071398","volume":"14","author":"MC Yu","year":"2008","unstructured":"Yu MC, Wu MH, Jou R: Extensively drug-resistant tuberculosis, Taiwan. Emerg Infect Dis. 2008, 14 (5): 849-850. 10.3201\/eid1405.071398.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"1599_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(07)70141-X","volume":"7","author":"ZF Udwadia","year":"2007","unstructured":"Udwadia ZF, Jain S, Rodrigues C, Mehta A: XDR tuberculosis in India: what's in a name?. Lancet Infect Dis. 2007, 7 (7): 441-442. 10.1016\/S1473-3099(07)70141-X.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1599_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0923-2508(02)01311-6","volume":"153","author":"I Mokrousov","year":"2002","unstructured":"Mokrousov I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E, Limeschenko E, Vyshnevskiy B, Narvskaya O, Rastogi N: Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA\/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol. 2002, 153 (4): 213-219. 10.1016\/S0923-2508(02)01311-6.","journal-title":"Res Microbiol"},{"issue":"5","key":"1599_CR34","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1128\/AAC.46.5.1417-1424.2002","volume":"46","author":"I Mokrousov","year":"2002","unstructured":"Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B: High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother. 2002, 46 (5): 1417-1424. 10.1128\/AAC.46.5.1417-1424.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1599_CR35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10096-003-0944-0","volume":"22","author":"I Mokrousov","year":"2003","unstructured":"Mokrousov I, Otten T, Vyazovaya A, Limeschenko E, Filipenko ML, Sola C, Rastogi N, Steklova L, Vyshnevskiy B, Narvskaya O: PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur J Clin Microbiol Infect Dis. 2003, 22 (6): 342-348. 10.1007\/s10096-003-0944-0.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-255\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:44:22Z","timestamp":1630514662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1599"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-255","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,28]]},"assertion":[{"value":"4 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"255"}}